Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ainos, Inc. (AIMD)
USD1.91
+0.01 (+0.53%)
US NASDAQ Healthcare Biotechnology
Address
8880 Rio San Diego Drive 92108
San Diego, CA, US
San Diego, CA, US
CEO
Chun-Hsien Tsai
Website
ainos.com
IPO
2021-01-08
CIK 1014763 ISIN US00902F4028
Also trades on
NASDAQ Capital Market · AIMD (USD)
NASDAQ Global Market · AIMDW (USD)
Description
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.91
+0.01 (+0.53%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
360.3K
Beta
2.43
Float Shares
1.83M
Free Float %
42.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.79% | -3.39% | +4.27% | +12.50% | -33.72% | +4.27% | -36.67% | -90.37% | -99.30% | -97.02% | -97.02% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.91
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-6.30
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+499.0% ★ Q1'26: -99.8% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-121.8% Q1'26: +100.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-7,487.9% Q1'26: -616,126.1% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-11,323.0% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-77.5% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%-55.1% ★ Q1'26: -100.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-1.19× Q1'26: -1.20× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-4.86M
OE per share TTM
-74.86
Owner's Yield
-65.42%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
98.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
3
Beneficial owners (>5%)
7
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Carbon Nano Technology Corporation (“TNCT”) | 5.50M | 40.23% | — | 5.50M | 5.50M | — | CO | Republic of China | 2024-08-21 | ↗ |
| 2 | CYTO BIOTECH, INC. | 3.00M | 6.70% | — | — | — | — | CO | TAIWAN | 2009-10-21 | ↗ |
| 3 | Stephen T. Chen, PhD | 2.70M | 13.39% | 2.70M | 763.00 | 2.70M | 763.00 | IN | United States & Taiwan | 2015-10-13 | ↗ |
| 4 | (“ASX”) | 2.31M | 27.40% | — | 2.31M | — | 10.00 | CO | Taiwan, Republic of China | 2024-05-08 | ↗ |
| 5 | ASE Test, Inc. (“ASE Test Taiwan”) | 2.31M | 27.40% | — | 2.31M | — | 10.00 | CO | Taiwan, Republic of China | 2024-05-08 | ↗ |
| 6 | Hayashibara Biochemical Laboratories, Inc. | 1.23M | 24.10% | 1.23M | — | 1.23M | — | CO | Japan | 1996-09-06 | ↗ |
| 7 | Joseph M. Cummins | 696.8K | 13.60% | 696.4K | 360.00 | 696.4K | 360.00 | IN | United States of America | 1996-09-06 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 37.3K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
3.33
Bullish
Ratio by volume
2.01
Bullish
Buys
10
Sells
3
Shares acquired
2.41M
Shares disposed
1.20M
Cash buys
4.00
Cash sales
—
Net activity
+1,206,423
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | chiang yao-chung | Director | P-Purchase | A | Common Stock | 129 | 1.70 | 219.30 | 829 | I | ↗ |
| 2026-04-30 | chiang yao-chung | Director | P-Purchase | A | Common Stock | 200 | 1.68 | 336.00 | 700 | I | ↗ |
| 2026-04-29 | chiang yao-chung | Director | P-Purchase | A | Common Stock | 100 | 1.75 | 175.00 | 500 | I | ↗ |
| 2026-04-15 | tsai chun-hsien | Director / Officer | A-Award | A | Common Stock | 300,000 | 1.61 | 483.0K | 710,372 | D | ↗ |
| 2026-04-15 | lee ting-chuan | Director | A-Award | A | Common Stock | 570,000 | 1.61 | 917.7K | 935,707 | D | ↗ |
| 2026-04-15 | TSAI CHUN-JUNG | Director | A-Award | A | Common Stock | 330,000 | 1.61 | 531.3K | 686,999 | D | ↗ |
| 2026-04-12 | ASE Test, Inc. | 10% Owner | P-Purchase | A | 6% Convertible Note due 2027 (previously due 2025) | 5,994 | 22.50 | 134.9K | 105,868 | D | ↗ |
| 2026-01-28 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | D | Common Stock | 46,000 | 2.17 | 99.8K | 989,925 | D | ↗ |
| 2026-01-09 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | D | Common Stock | 431 | 1.86 | 801.66 | 1,035,925 | D | ↗ |
| 2026-01-08 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | D | Common Stock | 850 | 1.80 | 1.5K | 1,036,356 | D | ↗ |
| 2025-11-25 | tsai chung-yi | Director | C-Conversion | D | RSU | 50,000 | 0.00 | — | 0 | D | ↗ |
| 2025-11-25 | tsai chun-hsien | Director / Officer | C-Conversion | D | RSU | 80,000 | 0.00 | — | 0 | D | ↗ |
| 2025-11-25 | lee ting-chuan | Director | C-Conversion | D | RSU | 80,000 | 0.00 | — | 0 | D | ↗ |
| 2025-11-25 | chiang yao-chung | Director | C-Conversion | D | RSU | 50,000 | 0.00 | — | 0 | D | ↗ |
| 2025-11-25 | chang wen-han | Director | A-Award | A | RSU | 50,000 | 0.00 | — | 0 | D | ↗ |
| 2025-11-25 | WEI PAO-SHENG | Director | A-Award | A | RSU | 50,000 | 0.00 | — | 0 | D | ↗ |
| 2025-11-25 | TSAI CHUN-JUNG | Director | C-Conversion | D | RSU | 80,000 | 0.00 | — | 0 | D | ↗ |
| 2025-11-25 | Lee Hsin-Liang Christopher | Officer | C-Conversion | D | RSU | 20,000 | 0.00 | — | 0 | D | ↗ |
| 2025-10-06 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | D | Common Stock | 7,000 | 3.59 | 25.1K | 1,037,206 | D | ↗ |
| 2025-10-02 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | D | Common Stock | 2,000 | 3.59 | 7.2K | 1,044,206 | D | ↗ |
| 2025-10-01 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | D | Common Stock | 1,700 | 3.46 | 5.9K | 1,046,206 | D | ↗ |
| 2025-09-30 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | D | Common Stock | 1,006 | 3.52 | 3.5K | 1,047,906 | D | ↗ |
| 2025-08-06 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | A | Common Stock | 20,000 | 2.95 | 59.0K | 1,048,912 | D | ↗ |
| 2025-08-05 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | A | Common Stock | 11,191 | 2.44 | 27.3K | 1,068,912 | D | ↗ |
| 2025-07-18 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | A | Common Stock | 7,000 | 2.81 | 19.6K | 1,080,103 | D | ↗ |
| 2025-07-17 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | A | Common Stock | 7,001 | 2.80 | 19.6K | 1,087,103 | D | ↗ |
| 2025-06-27 | TSAI CHUN-JUNG | Director | S-Sale | D | Common Stock | 10,000 | 0.50 | 5.0K | 1,384,997 | D | ↗ |
| 2025-06-25 | lee ting-chuan | Director | S-Sale | D | Common Stock | 2,894 | 0.51 | 1.5K | 1,428,538 | D | ↗ |
| 2025-06-25 | TSAI CHUN-JUNG | Director | S-Sale | D | Common Stock | 7,000 | 0.50 | 3.5K | 1,394,997 | D | ↗ |
| 2025-06-23 | Taiwan Carbon Nano Technology Corp | 10% Owner | S-Sale | A | Common Stock | 29,476 | 0.01 | 294.76 | 5,470,524 | D | ↗ |
| 2025-06-23 | TSAI CHUN-JUNG | Director | S-Sale | D | Common Stock | 10,000 | 0.50 | 5.0K | 1,401,997 | D | ↗ |
| 2025-06-23 | ASE Test, Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.01 per share | 29,476 | 0.01 | 294.76 | 58,887 | D | ↗ |
| 2025-06-19 | TSAI CHUN-JUNG | Director | S-Sale | D | Common Stock | 10,903 | 0.55 | 6.0K | 1,411,997 | D | ↗ |
| 2025-06-18 | TSAI CHUN-JUNG | Director | S-Sale | D | Common Stock | 5,000 | 0.52 | 2.6K | 1,422,900 | D | ↗ |
| 2025-04-08 | tsai chun-hsien | Director / Officer | A-Award | A | RSU | 900,000 | 0.00 | — | 0 | D | ↗ |
| 2025-04-08 | lee ting-chuan | Director | A-Award | A | Common Stock | 900,000 | 0.48 | 432.6K | 1,431,432 | D | ↗ |
| 2025-04-08 | TSAI CHUN-JUNG | Director | C-Conversion | D | RSU | 900,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-10 | tsai chung-yi | Director | A-Award | A | RSU | 150,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-10 | tsai chun-hsien | Director / Officer | C-Conversion | D | RSU | 200,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-10 | lee ting-chuan | Director | C-Conversion | D | RSU | 200,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-10 | chiang yao-chung | Director | C-Conversion | D | RSU | 150,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-10 | chang wen-han | Director | A-Award | A | Common Stock | 150,000 | 0.46 | 69.0K | 257,733 | D | ↗ |
| 2025-03-10 | WEI PAO-SHENG | Director | A-Award | A | RSU | 150,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-10 | TSAI CHUN-JUNG | Director | A-Award | A | Common Stock | 200,000 | 0.46 | 92.0K | 527,900 | D | ↗ |
| 2025-03-10 | Lee Hsin-Liang Christopher | Officer | A-Award | A | Common Stock | 250,000 | 0.46 | 115.0K | 276,376 | D | ↗ |
| 2025-03-10 | ASE Test, Inc. | 10% Owner | P-Purchase | A | 6% Convertible Note due 2027 (previously due 2025) | 499,377 | 4.50 | 2.25M | 499,377 | D | ↗ |
| 2025-01-31 | tsai chung-yi | Director | A-Award | A | RSU | 1,468 | 0.00 | — | 1,468 | D | ↗ |
| 2025-01-31 | chiang yao-chung | Director | C-Conversion | D | RSU | 1,468 | 0.00 | — | 0 | D | ↗ |
| 2025-01-31 | chang wen-han | Director | C-Conversion | D | RSU | 1,468 | 0.00 | — | 0 | D | ↗ |
| 2025-01-31 | WEI PAO-SHENG | Director | C-Conversion | D | RSU | 1,468 | 0.00 | — | 0 | D | ↗ |
| 2024-11-26 | tsai chun-hsien | Director / Officer | C-Conversion | D | RSU | 4,000 | 0.00 | — | 0 | D | ↗ |
| 2024-11-26 | lee ting-chuan | Director | C-Conversion | D | RSU | 4,000 | 0.00 | — | 0 | D | ↗ |
| 2024-11-26 | TSAI CHUN-JUNG | Director | A-Award | A | Common Stock | 208,797 | 0.46 | 96.0K | 323,900 | D | ↗ |
| 2024-11-26 | Lee Hsin-Liang Christopher | Officer | A-Award | A | Common Stock | 19,019 | 0.46 | 8.7K | 22,376 | D | ↗ |
| 2024-11-22 | tsai chun-hsien | Director / Officer | A-Award | A | RSU | 4,000 | 0.00 | — | 4,000 | D | ↗ |
| 2024-11-22 | lee ting-chuan | Director | A-Award | A | RSU | 4,000 | 0.00 | — | 4,000 | D | ↗ |
| 2024-11-22 | TSAI CHUN-JUNG | Director | A-Award | A | RSU | 4,000 | 0.00 | — | 4,000 | D | ↗ |
| 2024-11-22 | Lee Hsin-Liang Christopher | Officer | A-Award | A | RSU | 4,000 | 0.00 | — | 4,000 | D | ↗ |
| 2024-11-15 | tsai chun-hsien | Director / Officer | C-Conversion | D | RSU | 3,000 | 0.00 | — | 4,000 | D | ↗ |
| 2024-11-15 | lee ting-chuan | Director | C-Conversion | D | RSU | 4,200 | 0.00 | — | 5,600 | D | ↗ |
| 2024-11-15 | TSAI CHUN-JUNG | Director | C-Conversion | D | RSU | 4,200 | 0.00 | — | 5,600 | D | ↗ |
| 2024-09-15 | tsai chun-hsien | Director / Officer | C-Conversion | D | RSU | 17,511 | 0.00 | — | 99,232 | — | ↗ |
| 2024-09-15 | lee ting-chuan | Director | A-Award | A | Common Stock | 23,280 | 0.53 | 12.3K | 118,511 | — | ↗ |
| 2024-09-15 | TSAI CHUN-JUNG | Director | C-Conversion | D | RSU | 22,517 | 0.00 | — | 127,597 | — | ↗ |
| 2024-09-15 | Lee Hsin-Liang Christopher | Officer | A-Award | A | Common Stock | 3,357 | 0.53 | 1.8K | 3,357 | — | ↗ |
| 2024-08-22 | LIN LAWRENCE K | — | — | D | Non-Qualified Stock Options | 166,666 | 0.38 | 63.3K | 0 | — | ↗ |
| 2024-08-16 | tsai chung-jung | Director | A-Award | A | Common Stock | 16,200 | 0.71 | 11.5K | 88,386 | — | ↗ |
| 2024-08-16 | tsai chun-hsien | Director / Officer | A-Award | A | COMMON STOCK | 26,100 | 0.71 | 18.5K | 302,319 | — | ↗ |
| 2024-08-16 | lee ting-chuan | Director | A-Award | A | Common Stock | 14,400 | 0.71 | 10.2K | 95,231 | — | ↗ |
| 2024-08-15 | Taiwan Carbon Nano Technology Corp | 10% Owner | — | D | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 5,500,000 | — | ↗ |
| 2024-05-03 | ASE Test, Inc. | 10% Owner | — | D | 6% Convertible Note due 2027 | 2,000,000 | 4.50 | 9.00M | 0 | — | ↗ |
| 2024-03-18 | Lee Hsin-Liang Christopher | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-02-16 | tsai chung-jung | Director | C-Conversion | D | RSU | 16,200 | 0.00 | — | 111,400 | — | ↗ |
| 2024-02-16 | tsai chun-hsien | Director / Officer | A-Award | A | COMMONSTOCK | 26,100 | 0.87 | 22.7K | 276,219 | — | ↗ |
| 2024-02-16 | lee ting-chuan | Director | C-Conversion | D | RSU | 14,400 | 0.00 | — | 101,200 | — | ↗ |
| 2024-02-16 | Sung Meng Lin | Officer | A-Award | A | Common Stock | 1,050 | 0.87 | 912.77 | 61,050 | — | ↗ |
| 2024-02-16 | LIN LAWRENCE K | Officer | A-Award | A | CommonStock | 360 | 0.87 | 312.95 | 11,260 | — | ↗ |
| 2024-01-31 | tsai chung-yi | Director | C-Conversion | D | RSU | 1,466 | 0.00 | — | 1,466 | — | ↗ |
| 2024-01-31 | chiang yao-chung | Director | C-Conversion | D | RSU | 1,466 | 0.00 | — | 1,466 | — | ↗ |
| 2024-01-31 | chang wen-han | Director | C-Conversion | D | RSU | 1,466 | 0.00 | — | 1,466 | — | ↗ |
| 2024-01-31 | WEI PAO-SHENG | Director | C-Conversion | D | RSU | 1,466 | 0.00 | — | 1,466 | — | ↗ |
| 2023-11-25 | lee ting-chuan | Director | C-Conversion | D | RSU | 10,500 | 0.00 | — | 49,000 | — | ↗ |
| 2023-11-24 | tsai chung-yi | Director | A-Award | A | Common Stock | 250,000 | 0.60 | 150.0K | 257,333 | — | ↗ |
| 2023-11-24 | tsai chung-jung | Director | A-Award | A | Common Stock | 250,000 | 0.60 | 150.0K | 279,932 | — | ↗ |
| 2023-11-24 | tsai chun-hsien | Director / Officer | A-Award | A | COMMON STOCK | 880,000 | 0.60 | 528.0K | 1,250,598 | — | ↗ |
| 2023-11-24 | lee ting-chuan | Director | A-Award | A | Common Stock | 250,000 | 0.60 | 150.0K | 332,157 | — | ↗ |
| 2023-11-24 | chiang yao-chung | Director | A-Award | A | Common Stock | 250,000 | 0.60 | 150.0K | 267,333 | — | ↗ |
| 2023-11-24 | chang wen-han | Director | A-Award | A | Common Stock | 250,000 | 0.60 | 150.0K | 523,999 | — | ↗ |
| 2023-11-24 | WEI PAO-SHENG | Director | A-Award | A | Common Stock | 250,000 | 0.60 | 150.0K | 257,333 | — | ↗ |
| 2023-11-24 | Sung Meng Lin | Officer | A-Award | A | Common Stock | 300,000 | 0.60 | 180.0K | 300,000 | — | ↗ |
| 2023-11-24 | LIN LAWRENCE K | Officer | A-Award | A | Options | 11,111 | 0.00 | — | 11,111 | — | ↗ |
| 2023-11-15 | tsai chung-jung | Director | C-Conversion | D | RSU | 10,500 | 0.65 | 6.8K | 49,000 | — | ↗ |
| 2023-11-15 | tsai chun-hsien | Director / Officer | C-Conversion | D | RSU | 7,500 | 0.61 | 4.6K | 35,000 | — | ↗ |
| 2023-11-15 | lee ting-chuan | Director | A-Award | A | Common Stock | 10,500 | 0.65 | 6.8K | 82,157 | — | ↗ |
| 2023-08-15 | tsai chung-jung | Director | A-Award | D | RSU | 540,000 | 0.00 | — | 589,000 | — | ↗ |
| 2023-08-15 | tsai chun-hsien | Director / Officer | A-Award | A | RSU | 870,000 | 0.00 | — | 905,000 | — | ↗ |
| 2023-08-15 | Sung Meng Lin | Officer | A-Award | A | RSU | 35,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-06-30 | tsai chung-jung | Director | C-Conversion | D | RSU issuance | 10,500 | 1.06 | 11.1K | 59,500 | — | ↗ |
| 2023-06-30 | tsai chun-hsien | Director / Officer | C-Conversion | D | RSU issuance | 7,500 | 1.22 | 9.2K | 42,500 | D | ↗ |
| 2023-06-30 | lee ting-chuan | Director | C-Conversion | D | RSU issuance | 10,500 | 1.06 | 11.1K | 59,500 | — | ↗ |
| 2023-06-30 | Wu Hui-Lan | Officer | C-Conversion | D | RSU issuance | 5,250 | 1.22 | 6.4K | 29,750 | D | ↗ |
| 2023-05-24 | Sung Meng Lin | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-26 | lee ting-chuan | Director | P-Purchase | A | COMMON STOCK | 61,157 | 0.79 | 48.6K | 61,157 | D | ↗ |
| 2023-04-19 | AINOS INC | 10% Owner | S-Sale | D | Common Stock | 400,000 | 0.75 | 300.0K | 12,926,082 | — | ↗ |
| 2023-04-10 | tsai chung-yi | Director / Officer | A-Award | A | COMMON STOCK | 7,333 | 0.90 | 6.6K | 7,333 | — | ↗ |
| 2023-04-10 | chiang yao-chung | Director | C-Conversion | D | RSU | 7,333 | 0.90 | 6.6K | 14,667 | — | ↗ |
| 2023-04-10 | chang wen-han | Director | A-Award | A | COMMON STOCK | 7,333 | 0.90 | 6.6K | 7,333 | — | ↗ |
| 2023-04-10 | WEI PAO-SHENG | Director | C-Conversion | D | RSU | 7,333 | 0.90 | 6.6K | 14,667 | — | ↗ |
| 2023-04-07 | tsai chung-yi | Director | C-Conversion | D | RSU | 7,333 | 0.00 | — | 14,667 | — | ↗ |
| 2023-04-07 | chiang yao-chung | Director | C-Conversion | D | RSU | 7,333 | 0.00 | — | 14,667 | — | ↗ |
| 2023-04-07 | chang wen-han | Director | C-Conversion | D | RSU | 7,333 | 0.00 | — | 14,667 | — | ↗ |
| 2023-04-07 | WEI PAO-SHENG | Director | C-Conversion | D | RSU | 7,333 | 0.00 | — | 14,667 | — | ↗ |
| 2023-03-13 | ASE Test, Inc. | 10% Owner | — | D | 6% Convertible Note due 2025 | 282,666 | 7.50 | 2.12M | 0 | — | ↗ |
| 2022-11-14 | tsai chung-jung | Director | A-Award | A | RSU | 70,000 | 0.00 | — | 70,000 | — | ↗ |
| 2022-11-14 | lee ting-chuan | Director | A-Award | A | RSU | 70,000 | 0.00 | — | 70,000 | — | ↗ |
| 2022-10-26 | tsai chun-hsien | Director | C-Conversion | D | RSU | 5,000,000 | 1.89 | 9.45M | 0 | — | ↗ |
| 2022-10-24 | tsai chun-hsien | Director | A-Award | D | RSU | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-10-24 | Wu Hui-Lan | Director / Officer | C-Conversion | D | RSU | 2,000,000 | 1.89 | 3.78M | 0 | — | ↗ |
| 2022-08-09 | Wu Hui-Lan | Director / Officer | A-Award | A | Common Stock | 14,705 | 3.40 | 50.0K | 18,905 | — | ↗ |
| 2022-08-09 | AINOS INC | Director | A-Award | A | COMMON STOCK | 7,647,058 | 3.40 | 26.00M | 12,311,763 | — | ↗ |
| 2022-07-28 | tsai chung-yi | Director | A-Award | A | RSU | 330,000 | 0.00 | — | 330,000 | — | ↗ |
| 2022-07-28 | tsai chun-hsien | Director / Officer | A-Award | A | RSU | 5,000,000 | 0.00 | — | 5,000,000 | — | ↗ |
| 2022-07-28 | chiang yao-chung | Director | A-Award | A | RSU | 330,000 | 0.00 | — | 330,000 | — | ↗ |
| 2022-07-28 | chang wen-han | Director | A-Award | A | RSU | 330,000 | 0.00 | — | 330,000 | — | ↗ |
| 2022-07-28 | Wu Hui-Lan | Director / Officer | A-Award | A | Convertible Note | 50,000 | 50,000.00 | 2.50B | 50,000 | — | ↗ |
| 2022-07-28 | WEI PAO-SHENG | Director | A-Award | A | RSU | 330,000 | 0.00 | — | 330,000 | — | ↗ |
| 2022-06-27 | CHEN STEPHEN T | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-15 | WEI PAO-SHENG | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-31 | Wu Hui-Lan | Officer | A-Award | A | Convertible Note | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-03-17 | AINOS INC | Director | P-Purchase | A | Convertible Notes | 3,000,000 | 0.00 | — | 3,000,000 | — | ↗ |
| 2021-12-27 | LIN LAWRENCE K | — | D-Return | A | Convertible Promissory Note | 0 | 0.25 | — | 0 | — | ↗ |
| 2021-12-22 | chiu hsiu-chen | Director | G-Gift | A | COMMON STOCK | 3,001,500 | 0.19 | 570.3K | 3,001,500 | — | ↗ |
| 2021-12-22 | AINOS INC | 10% Owner | G-Gift | D | COMMON STOCK | 3,001,500 | 0.19 | 570.3K | 69,970,571 | — | ↗ |
| 2021-12-21 | tsai chun-hsien | Director / Officer | P-Purchase | A | Common Stock | 333,986 | 0.50 | 167.0K | 333,986 | — | ↗ |
| 2021-12-20 | tsai chung-jung | Director | P-Purchase | A | Common Stock | 133,986 | 0.50 | 67.0K | 133,986 | — | ↗ |
| 2021-12-20 | Wu Hui-Lan | Officer | A-Award | A | Common Stock | 63,000 | 0.50 | 31.5K | 63,000 | — | ↗ |
| 2021-12-20 | AINOS INC | 10% Owner | D-Return | D | COMMON STOCK | 20,742,929 | 0.50 | 10.37M | 69,970,571 | — | ↗ |
| 2021-12-06 | chiang yao-chung | Director | P-Purchase | A | Common Stock | 150,000 | 2.00 | 300.0K | 150,000 | — | ↗ |
| 2021-12-06 | chang wen-han | Director | P-Purchase | A | Common Stock | 4,000,000 | 0.25 | 1.00M | 4,000,000 | — | ↗ |
| 2021-12-06 | AINOS INC | 10% Owner | D-Return | D | Common Stock | 4,660,000 | 1.00 | 4.66M | 94,890,000 | — | ↗ |
| 2021-09-20 | LIN LAWRENCE K | — | — | D | Common Stock | 0 | 0.00 | — | 250,277 | — | ↗ |
| 2021-08-20 | Wu Hui-Lan | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-08-01 | LIN LAWRENCE K | — | A-Award | A | Non-Qualified Stock Option | 0 | 0.38 | — | 0 | — | ↗ |
| 2021-04-15 | tsai chung-yi | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-15 | tsai chung-jung | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-15 | tsai chun-hsien | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-15 | lee ting-chuan | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-15 | chiu hsiu-chen | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-15 | chiang yao-chung | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-15 | chang wen-han | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-15 | AINOS INC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 100,000,000 | — | ↗ |
| 2020-11-25 | LIN LAWRENCE K | — | A-Award | A | Stock Warrant Certificate | 0 | 0.27 | — | 0 | — | ↗ |
| 2020-10-12 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 400 | 0.14 | 56.00 | 783,000 | — | ↗ |
| 2020-10-09 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.13 | 13.00 | 782,600 | — | ↗ |
| 2020-10-08 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 400 | 0.13 | 52.00 | 782,300 | — | ↗ |
| 2020-10-05 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 0.22 | 44.00 | 781,900 | — | ↗ |
| 2020-09-28 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 300 | 0.18 | 54.00 | 781,700 | — | ↗ |
| 2020-09-22 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 0.20 | 40.00 | 781,400 | — | ↗ |
| 2020-09-21 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 800 | 0.16 | 128.00 | 781,200 | — | ↗ |
| 2020-09-17 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.22 | 22.00 | 780,400 | — | ↗ |
| 2020-09-11 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.18 | 18.00 | 780,300 | — | ↗ |
| 2020-09-03 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 300 | 0.21 | 63.00 | 780,200 | — | ↗ |
| 2020-09-02 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 0.21 | 42.00 | 779,900 | — | ↗ |
| 2020-08-27 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.21 | 21.00 | 779,700 | — | ↗ |
| 2020-08-24 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.21 | 21.00 | 779,600 | — | ↗ |
| 2020-08-19 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 300 | 0.21 | 63.00 | 779,500 | — | ↗ |
| 2020-08-14 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.22 | 22.00 | 779,200 | — | ↗ |
| 2020-08-10 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.21 | 21.00 | 779,000 | — | ↗ |
| 2020-08-07 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 400 | 0.21 | 84.00 | 778,900 | — | ↗ |
| 2020-07-31 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 500 | 0.30 | 150.00 | 778,000 | — | ↗ |
| 2020-07-30 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 50 | 0.23 | 11.50 | 777,500 | — | ↗ |
| 2020-07-01 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 50 | 0.22 | 11.00 | 777,450 | — | ↗ |
| 2020-06-25 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.22 | 22.00 | 777,400 | — | ↗ |
| 2020-06-23 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.22 | 22.00 | 777,300 | — | ↗ |
| 2020-05-26 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.23 | 23.00 | 777,200 | — | ↗ |
| 2020-05-19 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 50 | 0.23 | 11.50 | 777,100 | — | ↗ |
| 2020-05-15 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 50 | 0.23 | 11.50 | 777,050 | — | ↗ |
| 2020-05-14 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 50 | 0.23 | 11.50 | 12,413 | — | ↗ |
| 2020-05-13 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.23 | 23.00 | 777,000 | — | ↗ |
| 2020-04-28 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.23 | 23.00 | 776,900 | — | ↗ |
| 2020-04-23 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 50 | 0.23 | 11.50 | 776,800 | — | ↗ |
| 2020-04-21 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.27 | 27.00 | 776,700 | — | ↗ |
| 2020-04-17 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.23 | 23.00 | 776,600 | — | ↗ |
| 2020-04-16 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 0.23 | 46.00 | 776,500 | — | ↗ |
| 2020-04-15 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.22 | 22.00 | 776,300 | — | ↗ |
| 2020-04-14 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 0.22 | 44.00 | 776,200 | — | ↗ |
| 2020-04-09 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.24 | 24.00 | 776,000 | — | ↗ |
| 2020-04-07 | CHEN STEPHEN T | Director / Officer | P-Purchase | A | Common Stock | 100 | 0.24 | 24.00 | 775,900 | — | ↗ |
| 2020-03-31 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 0.25 | 50.00 | 775,800 | — | ↗ |
| 2020-03-30 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.25 | 25.00 | 775,600 | — | ↗ |
| 2020-03-26 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.25 | 25.00 | 775,500 | — | ↗ |
| 2020-03-18 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.25 | 25.00 | 12,363 | — | ↗ |
| 2020-03-13 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.24 | 24.00 | 775,400 | — | ↗ |
| 2020-03-12 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 200 | 0.24 | 48.00 | 775,300 | — | ↗ |
| 2020-03-05 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 0.28 | 28.00 | 775,100 | — | ↗ |
| 2020-02-18 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 0.29 | 580.00 | 775,000 | — | ↗ |
| 2020-02-12 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 0.30 | 600.00 | 773,000 | — | ↗ |
| 2020-02-07 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 0.30 | 300.00 | 771,000 | — | ↗ |
| 2020-02-05 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,250 | 0.25 | 312.50 | 769,250 | — | ↗ |
| 2020-01-31 | CHEN STEPHEN T | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 0.25 | 750.00 | 768,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-3.2K
Shares Outstanding
4.28M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2023 | Chun-Hsien Tsai President Chief Executive Officer | 95.9K | 16.2K | 1.17M | — | — | — | 1.29M | 91.27% | ↗ |
| 2 | 2023 | Meng-Lin Sung Former Chief Financial Officer | 57.4K | 9.7K | 218.9K | — | — | — | 286.0K | 76.54% | ↗ |
| 3 | 2023 | Lawrence K. Lin EVP of Operations | 144.0K | — | 14.8K | — | — | — | 158.8K | 9.31% | ↗ |
| 4 | 2023 | Hui-Lan Wu Former Chief Financial Officer | 37.3K | — | — | — | — | 1.6K | 39.0K | 0.00% | ↗ |
| 5 | 2006 | Dr. Joseph M. Cummins, Chairman of the Board, President and Chief Executive Officer | 181.4K | — | — | 400.0K | — | 216.0K | 397.4K | 100.65% | ↗ |
| 6 | 2006 | Mr. Martin J. Cummins, Vice President of Clinical and Regulatory Affairs | 97.9K | — | — | 400.0K | — | — | 97.9K | 408.72% | ↗ |
| 7 | 2006 | Dr. Gary W. Coy, Vice President and Chief Financial Officer | 88.5K | — | — | 400.0K | — | — | 88.5K | 451.76% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
| Filing date | Form type | Filing |
|---|---|---|
| 2025-10-01 | DEF 14A | ↗ |
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chun-Hsien Tsai | Chief Executive Officer, President & Chairman of the Board | 217.0K | male |
| Hsin-Liang Lee | Chief Financial Officer | 159.6K | male |
| Chih-Heng Lu | Director of Corporate Developoment | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AIMD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
